COVID-19 restrictions curb J&J’s OTC business

29 January 2021 - Deborah Wilkes

Premium

Worldwide sales at Johnson & Johnson’s (J&J’s) OTC business declined in the fourth quarter of 2020 as measures to control the COVID-19 pandemic meant fewer people suffered from coughs, colds and flu.

Click tags below for more information on topics:

Johnson & Johnson COVID-19

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: